If muc1 is positive in pancreatic adenocarcinoma with mutation of KRAS G12V mutation what will be the response of anti muc1 drugs
MUC1 KRAS pancreatic adenocarcinoma anti-MUC1 therapy
anti-MUC1 therapy KRAS G12V pancreatic adenocarcinoma response 2024 2025
MUC1 pancreatic cancer immunotherapy CAR-T
KRAS G12V pancreatic ductal adenocarcinoma MUC1 expression
MUC1 KRAS oncogene signaling tumor immune evasion
MUC1 anti-MUC1 therapy KRAS G12V pancreatic cancer response
MUC1 KRAS interaction signaling pathway cancer